ArticleCancer cell international2022

HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry.

Laura Morsberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.